Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The synthesis of Navelbine prototype of a new series of vinblastine derivatives.

× No keyword cloud information.

23 in total

Review 1. Breast cancer therapies in development. A review of their pharmacology and clinical potential.

Authors: D de Valeriola; A Awada; J A Roy; A Di Leo; L Biganzoli; M Piccart
Journal: Drugs Date: 1997-09 Impact factor: 9.546

2. Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines.

Authors: A Photiou; M N Sheikh; D Bafaloukos; S Retsas
Journal: J Cancer Res Clin Oncol Date: 1992 Impact factor: 4.553

Review 3. Plant-derived natural product research aimed at new drug discovery.

Authors: Hideji Itokawa; Susan L Morris-Natschke; Toshiyuki Akiyama; Kuo-Hsiung Lee
Journal: J Nat Med Date: 2008-04-22 Impact factor: 2.343

4. Involvement of Toll-like receptor 4 in vinorelbine-induced vascular endothelial injury.

Authors: Weiwei Qian; Liyan Gao; Chong Chen; Yingchun Tan; Ying Zhou; Zhenyu Li
Journal: Exp Ther Med Date: 2015-05-14 Impact factor: 2.447

5. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine.

Authors: E K Rowinsky; M J Citardi; D A Noe; R C Donehower
Journal: J Cancer Res Clin Oncol Date: 1993 Impact factor: 4.553

6. Synthesis of C-15 vindoline analogues by palladium-catalyzed cross-coupling reactions.

Authors: Peter D Johnson; Jeong-Hun Sohn; Viresh H Rawal
Journal: J Org Chem Date: 2006-09-29 Impact factor: 4.354

Review 7. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors: K L Goa; D Faulds
Journal: Drugs Aging Date: 1994-09 Impact factor: 3.923

8. Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer.

Authors: Elisabeth Bergen; Anna S Berghoff; Margaretha Rudas; Peter Dubsky; Catharina De Vries; Claudia Sattlberger; Robert M Mader; Flora Zagouri; Cornelia Sparber; Florian Fitzal; Michael Gnant; Andrea Rottenfusser; Christoph C Zielinski; Matthias Preusser; Guenther G Steger; Rupert Bartsch
Journal: Breast Care (Basel) Date: 2014-10 Impact factor: 2.860

9. Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma. A phase II study.

Authors: A Testolin; G Recher; V Cristoferi; G Gasparini
Journal: Invest New Drugs Date: 1994 Impact factor: 3.850

Review 10. The current and future place of vinorelbine in cancer therapy.

Authors: E Cvitkovic; J Izzo
Journal: Drugs Date: 1992 Impact factor: 9.546